yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q55000725-17E10B1F-2B04-486B-8F1E-27C6C5B72E89
Q55000725-17E10B1F-2B04-486B-8F1E-27C6C5B72E89
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55000725-17E10B1F-2B04-486B-8F1E-27C6C5B72E89
Combination immuno-oncology therapy with immune checkpoint blockers targeting PD-L1, PD-1 or CTLA4 and epigenetic drugs targeting MYC and immune evasion for precision medicine.
P2860
Q55000725-17E10B1F-2B04-486B-8F1E-27C6C5B72E89
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55000725-17E10B1F-2B04-486B-8F1E-27C6C5B72E89
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ca14cfb0568c284e11bd1697acd2f25892918d42
P2860
Therapeutics Targeting FGF Signaling Network in Human Diseases.